1-8 of 8
Kalpana Bakshi, BS, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Update On The Safety and Efficacy Of EXTENDed Treatment With Eltrombopag (EPAG) In Adults With Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Mansoor N. Saleh, MD, Raymond S.M. Wong, Paul Burgess, Kalpana Bakshi, BS, MS, Geoffrey W. Chan, MD, Christine K. Bailey, PhD
Journal: Blood
Blood (2013) 122 (21): 2315.
https://doi.org/10.1182/blood.V122.21.2315.2315
Published: 2013
Journal Articles

Evaluation Of The Effects Of Long-Term Treatment With Eltrombopag On Bone Marrow In Patients With Chronic Immune Thrombocytopenia (ITP) — Data From The EXTEND Study

Russell K. Brynes, MD, Attilio Orazi, MD, Kalpana Bakshi, BS, MS, Christine K Bailey, PhD, Geoffrey W. Chan, MD
Journal: Blood
Blood (2013) 122 (21): 326.
https://doi.org/10.1182/blood.V122.21.326.326
Published: 2013
Journal Articles

Baseline Laboratory Parameters Potentially Associated with Thrombophilia in Patients with Chronic ITP.

Raymond S.M. Wong, Kalpana Bakshi, BS, MS, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2191.
https://doi.org/10.1182/blood.V120.21.2191.2191
Published: 2012
Journal Articles

A Longitudinal Prospective Study Evaluating the Effects of Eltrombopag Treatment On Bone Marrow in Patients with Chronic Immune Thrombocytopenia: Interim Analysis At 1 Year.

Russell K. Brynes, MD, Attilio Orazi, MD, Raymond S.M. Wong, Kalpana Bakshi, BS, MS, Christine K Bailey, PhD, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2195.
https://doi.org/10.1182/blood.V120.21.2195.2195
Published: 2012
Journal Articles

Health-Related Quality of Life in Children with Chronic Immune Thrombocytopenia Treated with Eltrombopag in the PETIT Study.

Victor S. Blanchette, FRCP, Kelly M Grotzinger, Lisa Marcello, BA, MS, Kalpana Bakshi, BS, MS, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2197.
https://doi.org/10.1182/blood.V120.21.2197.2197
Published: 2012
Journal Articles

Long-Term Safety and Efficacy of Eltrombopag in Adults with Chronic Immune Thrombocytopenia (ITP): Report of up to 5.5 Years of Treatment in EXTEND.

Mansoor N Saleh, MD, Gregory Cheng, James B Bussel, MD, Paul Burgess, Kalpana Bakshi, BS, MS, Andres Brainsky, MD, Christine K Bailey, PhD
Journal: Blood
Blood (2012) 120 (21): 2198.
https://doi.org/10.1182/blood.V120.21.2198.2198
Published: 2012
Journal Articles

Efficacy and Safety of Eltrombopag in Elderly Patients with Chronic Immune Thrombocytopenia: Analysis of Five Clinical Trials,

Harold J. Olney, MD, Ingrid Pabinger, MD, Bhabita Mayer, MSc, Kalpana Bakshi, BS, MS, Christine K Bailey, PhD, Andres Brainsky, MD
Journal: Blood
Blood (2011) 118 (21): 3294.
https://doi.org/10.1182/blood.V118.21.3294.3294
Published: 2011
Journal Articles

Evaluation of Bone Marrow Reticulin in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Treated with Eltrombopag – Data From the EXTEND Study

Russell K. Brynes, MD, Attilio Orazi, MD, Shalini Verma, MD, Andres Brainsky, MD, Christine K Bailey, PhD, Kalpana Bakshi, BS, MS
Journal: Blood
Blood (2011) 118 (21): 528.
https://doi.org/10.1182/blood.V118.21.528.528
Published: 2011